Measuring GenAI ROI: Outcomes That Matter

Most GenAI pilots succeed and most GenAI programs stall. The gap is rarely the technology — it is that nobody defined, before building, what business result would justify scaling. 'The demo was impressive' is not a line item.

Decide the metric before the model

Every durable GenAI business case reduces to one of four outcome families: effort removed (hours of manual work eliminated), speed gained (cycle time from request to result), quality improved (error rates, rework, compliance findings), or revenue affected (conversion, retention, capacity to serve). Pick the one your use case moves, define how it is measured today, and capture that baseline before the first sprint. Without the 'before', the 'after' is an anecdote.

Measure the workflow, not the model

Model-level metrics — accuracy, groundedness, latency — are necessary but not sufficient. The number leadership should see is workflow-level: not 'the model extracts fields at 94% accuracy' but 'invoices now post same-day at 78% touchless rate, and the team redeployed eleven FTEs of effort to exception handling and supplier management.' The translation from model metric to workflow metric is where most measurement programs quietly fail.

Three ways GenAI value evaporates

• Saved minutes that never become saved cost: time freed in fragments across hundreds of people is real but invisible unless roles, queues, or targets change to absorb it.
• Quality regressions that offset speed: faster first drafts with higher rework rates can net out negative — measure rework, not just throughput.
• Pilot economics that ignore run costs: inference, retrieval infrastructure, evaluation, and the human review queue are the real unit economics; extrapolate them, not the demo.

A simple, honest ROI model

For each use case, track four numbers quarterly: baseline cost or cycle time, current cost or cycle time, run cost of the AI system (including review effort), and adoption rate. Value realized is the delta times adoption, minus run cost. It fits on one slide, it survives finance scrutiny, and it makes scale-or-stop decisions unemotional.

Treat the measurement system as part of the product. The organizations getting compounding returns from GenAI are not the ones with the most models in production — they are the ones that can say, with evidence, which models earned their place there.